Intravenous drug abusers are commonly found to have abnormal liver function tests and hepatic histology. Abnormal liver function tests, most commonly raised transaminases, have been found in 29 to 83% of drug abusers and histological abnormalities have included chronic persistent hepatitis, chronic active hepatitis, alcohol related liver disease, acute hepatitis and occasionally cirrhosis. 1 The aetiological factors are largely unknown. A direct toxic effect of the drugs seems unlikely as morphine given to rhesus monkeys and human volunteers does not cause biochemical abnormalities of liver function. 6 7 In addition, drug abusers changing from intravenous heroin to oral methadone replacement therapy show no significant improvement in liver function tests with time. 8 Hepatitis B virus (HBV) infection is more common in intravenous drug abusers than in the normal population but chronic HBV infection only accounts for a small number of those with persistent biochemical and histological abnormalities.3 4 
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The incidence of antibodies to hepatitis A virus has been found to be no different from controls and chronic infection does not occur.4 Before the discovery of other transmissable causes of acute and chronic hepatitis, past infection with HBV,2 3 12 drugs other than heroin or possible drug contaminants,15 16 talc granulomas17 and alcohol were all considered possible candidates responsible for the unexplained abnormalities of liver function tests and histology.
The aim of this study was to elucidate further the role of the hepatitis viruses and other agents in the cause of hepatitis in a clinic population of drug abusers. reticulin method, Shikata's orcein stain, the periodic acid Schiff stain after amylase digestion and Perls' method for iron. Seven of the eight cases had liver tissue taken for electron microscopy. This was fixed in 3% (cacodylate buffered) glutaraldehyde and postfixed in 1% osmium tetroxide. The tissue was embedded in Lemix and ultrathin sections were stained with uranyl acetate and Reynolds lead citrate. As a control liver tissue from six cases of chronic hepatitis B were similarly prepared. Ultrathin sections were examined under a Philips 201 electron microscope for nuclear and cytoplasmic changes such as tubular and dense membranous structures. In five of the eight cases a portion of liver was snap frozen in OCT and examined for HBV markers by immunofluorescence. HBsAg was detected by indirect immunofluorescence using an IgG, class monoclonal antibody and tetraethylrhodamine isothiocyanate conjugated goat antimouse IgG, as a second layer. HBcAg was detected by direct immunofluorescence using an FITC conjugated human antiserum to HBcAg.
Methods

Results
Sixty one out of 111 patients had a raised aspartate aminotransferase. In 25 patients this was less than twice the upper limit of normal. Bilirubin and alkaline phosphatase were raised with aspartate transaminase in seven and 12 patients respectively. Total protein and albumin were normal in all patients.
Seventy two per cent of the patients had some marker of hepatitis B virus infection (Table) . Sixty per cent had anti-HBs and 5% HBsAg indicating past and current infection respectively. Eight per cent had anti-HBc alone. Of the six patients who were HBsAg positive, two had an acute hepatitis and four were carriers having been positive for more than six months. Of the 56% who had anti-HAV none had serological evidence of recent infection. Only four of 116 patients (3.4%) were positive for a NANB associated antigen and three of these had normal liver function tests. None of these patients had liver biopsies.
Abnormalities in liver function tests were as frequent in patients with markers of hepatitis B virus infection as in those without (60% and 52% respectively) and as frequent in those with markers of past HAV infection as in those without (53% and 57% respectively). There was no trend towards an increasing incidence of HBV markers or abnormal liver function tests with the length of intravenous drug addiction prior to entry into the study (Fig. 1) . admitted. Interestingly also, 13% and 16% of our patients had a past history of blood transfusions or tattoos respectively. There was no relationship between the prevalence of HBV infection and duration of addiction, suggesting that the infection is acquired early, perhaps in the first two years of intravenous drug abuse. This is in accord with the finding that the majority of intravenous drug abusers with acute hepatitis had been addicted for less than a year.22 As in other studies, however,4 9 12 abnormalities in liver function tests were as frequent 420 in patients with markers of HBV infection as in those without; 60% and 52% respectively. Furthermore, the majority of those with markers, had evidence of past infection. It is therefore, unlikely that HBV infection was the major cause of abnormal liver function tests in our patients.
Fifty six per cent of our patients had past hepatitis A virus infection. This figure is slightly higher than that reported by Boughton4 and much higher than that of a normal population of a similar age group and social class in London (==30%).23 This might be explained by the frequent travel, as part of the drug culture, to countries with a high prevalence of HAV infection. Acute infection with hepatitis A virus, however, does not explain the abnormal liver function test in our patients and abnormalities of liver function tests were as frequent in those with markers of past HAV infection as in those without. Furthermore, current infection with 6 agent, CMV or EBV viruses, excessive alcohol consumption or the concurrent taking of hepatotoxic drugs does not explain the high prevalence of abnormal liver function tests.
The NANB associated antigen has been found in 40% of cases of acute postinfusion NANB hepatitis in haemophiliacs.2' It' was also found in 24% (five out of 17) of sporadic acute NANB hepatitis (four of whom were drug addicts) and in 19% of patients attending a haemophiliac centre. In our patients, however, the prevalence of this antigen is similar to that in controls, patients with non-viral liver disease and miscellaneous non-hepatic diseases (0-4%). In our study only two of the 62 patients with raised transminases had a clinical acute hepatitis and in both this was due to HBV infection. The majority of patients had a persistent mild rise of transaminase and those biopsied had a chronic hepatitis. It is possible that the NANB associated antigen which is present in acute infection in haemophiliacs, was present in low concentration in some of our patients and not detected by the assay. Alternatively, as there is more than one parenterally transmitted NANB virus as shown by cross challenge experiments in chimpanzees,24 25 31 it is conceivable that the predominant type of NANB hepatitis occurring in drug addicts is different to that seen in haemophiliacs receiving factor VIII concentrates.
There was no relationship between the prevalence of abnormal liver function tests and duration of addiction, suggesting as with HBV infection, that whatever agent is responsible for the abnormality, it is encountered in the first two years of intravenous drug abuse.
The light microscopic appearance corresponds to that described in other series of chronic non-A, non-B hepatitis. 
